Supercritical fluid technology for enhanced drug delivery

Expert Opinion on Drug Delivery

Volumn 2, Issue 4, 2005, Pages 747-761

  Pathak, Pankaj ^a   Meziani, Mohammed J ^a   Sun, Ya Ping ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

Aqueous suspension; Drug; Nanoparticle; Polymer; RESOLV; Stabilisation; Supercritical fluids

Indexed keywords

ACETYLSALICYLIC ACID; ACRYLIC ACID DERIVATIVE; AMPHOTERICIN B; DODECYL SULFATE SODIUM; DRUG CARRIER; IBUPROFEN; LIPOSOME; MICROSPHERE; NANOPARTICLE; NAPROXEN; NIFEDIPINE; PHENANTHRENE; PHOSPHATIDYLCHOLINE; POLYLACTIC ACID; POLYMER; PROGESTERONE; SALICYLIC ACID; SOLVENT; TESTOSTERONE;

ANTIFUNGAL ACTIVITY; AQUEOUS SOLUTION; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOTECHNOLOGY; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG SOLUBILITY; DRY POWDER; EMULSION; EQUIPMENT DESIGN; HUMAN; HYDROPHOBICITY; MICROEMULSION; MYCOSIS; NANOTECHNOLOGY; NEPHROTOXICITY; PARTICLE SIZE; PRECIPITATION; REVIEW; SCANNING ELECTRON MICROSCOPY; SUPERCRITICAL FLUID;

DRUG DELIVERY SYSTEMS; MICROSCOPY, ELECTRON, SCANNING; NANOSTRUCTURES; POLYMERS; SOLVENTS; SUSPENSIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 22844436560     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2.4.747     Document Type: Review

References (130)

1. LIPINSKI CA: Avoiding investment in doomed drugs, is poor solubility an industry wide problem? Curr. Drug Dis. (2001):17-19.
2. LIPINSKI CA: Poor aqueous solubility an industry wide problem in drug discovery. Am. Pharm. Rev. (2002) 5:82-85.
3. BROADHEAD J, ROUAN SK, RHODES CT: The spray drying of pharmaceuticals. Drug Dev. Ind. Pharm. (1992) 18(11-12):1169-1206.
4. MASTERS K: Spray Drying Handbook, (3rd Edition). K Masters (Ed.), John Wiley & Sons, New York, NY, USA (1979).
5. MULLER RH, BENITA S, BOHM B: Emulsions and nanosuspensions for the formulation of poorly soluble drugs. RH Muller, S Benita, B Bohm (Eds), Medpharm Scientific, Stuttgart, Germany (1998).
6. WIEDMANN TS, DECASTRO L, WOODS RW: Nebulization of nanocrystals: production of a respirable solid-in-liquid-in-air colloidal dispersion. Pharm. Res. (1997) 14(1):112-116.
7. ZHENG JY, BOSCH HW: Sterile filtration of nanocrystal drug formulations. Drug Dev. Ind. Pharm. (1997) 23(11):1087-1093.
8. KIBBE AH: Handbook of pharmaceutical excipients (3rd Edition). AH Kibbe (Ed.), AphA and PhP, Washington DC, USA (2000).
9. REBER LA, SCHOTT H: Colloidal dispersions. In: Remingtons Pharmaceutical Sciences. A Osol, JE Hoover et al. (Eds), Mack Pub. Co., Easton, Pa. USA (1975):299-321.
10. DE JAEGHERE F, DOELKER E, GURNY R: Encyclopedia of Controlled Drug Delivery. E Mathiowitz (Ed.), Wiley, New York, NY, USA (1999) 2:641.
11. QUINTANAR-GUERRRO D, ALLEMANN E, FESSI H, DOELKAR E: Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev. Ind. Pharm. (1998) 24(12):1113-1128.
12. VANDERHOFF JW. Pharmaceutical Dosage Forms: Disperse Systems, (2nd Edition). HA Lieberman, MM Rieger, GS Banker (Eds), Marcel Dekker, New York, NY, USA (1996) 1:91.
13. JONES AG: Controlled Particle, Droplet and Bubble Formation. DJ Wedlock (Ed.), Butterworth-Heinemann, Oxford, UK (1994):61.
14. NAKANO M: Places of emulsions in drug delivery. Adv. Drug. Deliv. Rev. (2000) 45(1):1-4.
15. LAWRENCE M, REES G: Microemulsion-based media as novel drug delivery systems. Adv. Drug. Deliv. Rev. (2000) 45(1):89-121.
16. LEUNER C, DRESSMAN J: Improoving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. (2000) 50(1):47-60.
17. STELLA V, RAJEWSKI R: Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. (1997) 14:556-567.
18. ALLEN TM: Liposomes: oppurtunities in drug delivery. Drugs (1997) 54(Suppl. 4):8-14.
19. COUVREUR P, DUBRNET C, PUISIEUX F: Controlled drug-delivery with nanoparticles - current possibilities and future trends. Euro. J. Pharm. Biopharm. (1995) 41(1):2-13.
20. PACE S, PACE GW, PARIKH I, MISHRA A: Novel injectable formulations of insoluble drugs. Pharm. Tech. (1999) 23:116.
21. JACOBS C, KAYSER O, MULLER RH: Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int. J. Pharm. (2000) 196(2):161-164.
22. MERISKO-LIVERSIDGE E, LIVERSIDGE GG, COOPER EG: Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. (2003) 18(2):113-120.
23. MULLER RH, JACOBS C, KAYSER O: Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. (2001) 47(1):3-19.
24. COOPER E: Nanoparticles in drug delivery. Nanotech. Symp. NIH. (2000).
25. LOPER A: Poorly soluble compounds: Vehicle selection and solubilization. Land O'lakes Conference. Drug. Metab. Pharmacokinet. (1999).
26. MOLLET H, GRUBENMANN A: Formulierungstechnik. H Mullet, A Grubenmann (Eds), Wiley-VCH, Weinheim, Germany (2000).
27. PETERS D: Ultrasound in materials chemistry. J. Mater. Chem. (1996) 6(10):1605-1618.
28. LAGALY LG, SCHULZ O, ZIMEHL R: Dispersionen und Emulsionen. LG Lagaly, O Schulz, R Zimehl (Eds), Steinkopff, Darmstadt, Germany (1997).
29. HERBST RW, HUNGER K: Industrial Organic Pigments. RW Herbst, K Hunger (Eds), Wiley-VCH, Weinheim, Germany (1997).
30. MULLER RH, BOHM BH, GRAU MJ: Nanosuspensions-formulations for poorly soluble drugs with poor bioavailability-1st communication: production and properties. Pharm. Ind. (1999) 61(1):74-78.
31. MULLER RH, CORNELIA MK: Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles. J. Biotechnol. (2004) 113:151-170.
32. LIVERSIDGE GG, CUNDY KC: Particle-size reduction for improvement of oral bioavailability of hydrphobic drugs. 1. Absolute oral bioavailabilty of nanocrystalline danazol in beagle dogs. Int. J. Pharm. (1995) 125(1):91-97.
33. FLOYD AG: Top ten consideration in the development of parenteral emulsions. Pharm. Sci. Tech. (1999) 2(4):134-143.
34. SERAJUDDIN AT: Solid dispersions of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. (1999) 88(10):1058-1066.
35. KRAUSE K, MULLER RH: Production and characterization of highly concentrated nanosuspensions by high pressure homogenization. Int. J. Pharm. (2001) 214:21-24.
36. TOM JW, DEBENEDETTI PG: Particle formation with supercritical fluids - a review. J. Aerosol. Sci. (1991) 22(5):555-584.
37. DEBENEDETTI PG: Supercritical fluids as particle formation media. In: Supercritical Fluids: Fundamentals for Application. Kluwer Academic Publishers, Boston, MA, USA (1994) 273:719.
38. VEMAVARAPU C, MOLLAN MJ, LODAYA M, NEEDHAM TE: Design and process aspects of laboratory scale SCF particle formation systems. Int. J. Pharm. (2005) 292(1-2):1-16.
39. REVERCHON E, DELLA-PORTA G: Supercritical fluids-assisted micronization techniques. Low-impact routes for particle production. Pure Appl. Chem. (2001) 73(8):1293-1297.
40. KROBER H, TEIPAL U, KRAUSE H: Manufacture of submicron particles via expansion of supercritical fluids. Chem. Eng. Technol. (2000) 23(9):763-765.
41. HELFGEN B, TURK M, SCHABER K: Theoretical and experimental investigations of the micronization of organic solids by rapid expansion of supercritical solutions. Powder. Technol. (2000) 110(1-2):22-28.
42. 2 and cryogenic spray-freezing technologies. Drug Dev. Ind. Pharm. (2001) 27(10):1003-1015.
43. YORK P: Strategies for particle design using supercritical fluid technologies. Pharm. Sci. Technol. Today (1999) 2(11):430-440.
44. KOMPELLA UB, KOUSHIK K: Preparation of drug delivery systems using supercritical fluid. Crit. Rev. Ther. Drug Carrier Syst. (2001) 18:173-199.
45. SUBRAMANIAM B, RAJEWSKI RA, SNAVELY K: Pharmaceutical processing with supercritical carbon dioxide. J. Pharm. Sci. (1997) 86(8):885-890.
46. JUNG J, PERRUT M: Particle design using supercritical fluids: literature and patent survey. J. Supercrit. Fluids (2001) 20(3):179-219.
47. STANTON LA, DEHGHANI F, FOSTER NR: Improving drug delivery using polymers and supercritical fluid technology. Aust. J. Chem. (2002) 55(6-7):443-447.
48. FAGES J, LOCHARD H, LETOURNEAU JJ, SAUCEAU M, RODIER E: Particle generation for pharmaceutical applications using supercritical fluid technology. Powder Technol. (2004) 141(3):219-226.
49. YOUNG TJ, MAWSON S, JOHNSTON KP, HENRIKSEN IB, PACE GW, MISHRA AK: Rapid expansion from supercritical to aqueous solution to produce submicron suspensions of water-insoluble drugs. Biotech. Progress. (2000) 16(3):402-407.
50. TAN HS, BORSADIA S: Particle formation using supercritical fluids: Pharmaceutical applications. Expert Opin. Ther. Pat. (2001) 11(5):861-872.
51. DEL VALLE EM, GALAN MA: Supercritical fluid technique for particle engineering: drug delivery applications. Rev. Chem. Eng. (2005) 21(1):33-69.
52. YORK P, KOMPELLA UB, SHEKUNOV BY: Supercritical Fluid Technology for Drug Product Development. Marcel Dekker, New York, NY, USA (2004).
53. DATE AA, PATRAVALE VB: Current strategies for engineering drug nanoparticles. Curr. Opin. Colloid Interface Sci. (2004) 9(1-3):222-235.
54. HU J, JOHNSTON KP, WILLIAMS RO 3rd: Nanoparticle engineering proceses for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev. Ind. Pharm. (2004) 30(3):233-245.
55. MEZIANI MJ, PATHAK P, HUREZEANU R, THIES MC, ENICK RM, SUN YP: Supercritical-fluid processing technique for nanoscale polymer particles. Angew. Chem. Int. Ed. (2004) 43(6):704-707.
56. PATHAK P, MEZIANI MJ, DESAI T, SUN YP: Nanosizing drug particles in supercritical fluid processing. J. Am. Chem. Soc. (2004) 126(35):10842-10843.
57. SUN YP, MEZIANI MJ, PATHAK P, QU L: Polymeric nanoparticles from rapid expansion of supercritical-fluid solution. Chem. Eur. J. (2005) 11(5):1366-1373.
58. SAUCEAU M, LETOURNEAU JJ, FREISS B, RICHON D, FAGES J: Solubility of eflucimibe in supercritical carbon dioxide with or without a co-solvent. J. Supercrit. Fluids (2004) 31(2):133-140.
59. TING SST, MACNAUGHTON SJ, TOMASKO DL, FOSTER NR: Solubilty of naproxen in supercritical carbon dioxide with and without cosolvents. Ind. Eng. Chem. Res. (1993) 32(7):1471-1481.
60. DEBENEDETTI PG, TOM JW, KWAUK X, YEO SD: Rapid expansion of supercritical solutions (RESS)-fundamentals and applications. Fluid Phase Equilib. (1993) 82:311-321.
61. REVERCHON E: Supercritical antisolvent precipitation of micro- and nano-particles. J. Supercrit. Fluids (1999) 15(1):1-21.
62. WANG Y, PFEFFER R, DAVE R, ENICK R: Polymer encapsulation of fine particles by a supercritical antisolvent process. AIChE J. (2005) 51(2):440-455.
63. WINTERS MA, KNUTSON BL, DEBENEDETTI PG et al.: Precipitation of proteins in supercritical carbon dioxide. J. Pharm. Sci. (1996) 85(6):586-594.
64. PERRUT M: Supercritical fluids applications in the pharmaceutical industry. STP. Pharma. Sci. (2003) 13(2):83-91.
65. JOVANOVIC N, BOUCHARD A, HOFLAND GW, WITKAMP GJ, CROMMELIN DJ, JISKOOT W: Stabilization of proteins in dry powder formulations using supercritical fluid technology. Pharm. Res. (2004) 21(11):1955-1969.
66. CHATTOPADHYAY P, GUPTA RB: Protein nanoparticles formation by supercritical antisolvent with enhanced mass transfer. AIChE J. (2002) 48(2):235-244.
67. DIXON DJ, JOHNSTON KP, BRODEMIER RA: Polymeric materials formed by precipitation with a compressed fluid antisolvent. AIChE J. (1993) 39(1):127-139.
68. FALK R, RANDOLPH TW, MEYER JD, KELLEY RM, MANNING MC: Controlled release of ionic compounds from poly(L-lactide) microspheres produced by precipitation with a compressed antisolvent. J. Control. Release (1997) 44(1):77-85.
69. SLOAN R, HOLLOWOOD ME, HUMPREYS GO, ASHRAF W, YORK P: Supercritical fluid processing: preparation of stable protein particles. Proceedings of the 5th Meeting on Supercritical Fluids. (1998):301-306.
70. KRUKONIS VJ: Supercritical fluids nucleation of difficult-to-comminute solids. Annual Meeting AIChE. (1984).
71. LELE AK, SHINE AD: Effect of RESS dynamics on polymer morphology. Ind. Eng. Chem. Res. (1994) 33(6):1476-1485.
72. MATSON DW, PETERSEN RC, SMITH RD: Formation of silica powders from the rapid expansion of supercritical solutions. Adv. Ceramic Mat. (1986) 1:242-246.
73. MATSON DW, FULTON JL, PETERSEN RC, SMITH RD: Rapid expansion of supercritical fluid solutions - solute formation of powders, thin-films, and fibers. Ind. Eng. Chem. Res. (1987) 26(11):2298-2306.
74. MATSON DW, PETERSEN RC, SMITH RD: Production of powders and films by the rapid expansion of supercritical solutions. J. Mater. Sci. (1987) 22(6):1919-1928.
75. ECKERT CA, KNUTSON BL, DEBENEDETTI PC: Supercritical fluids as solvents for chemical and materials processing. Nature (1996) 383(6598):313-318.
76. MCHUGH MA, KRUKONIS VJ: Supercritical Fluid Extraction: Principles and Practice. 2nd Edition. Butterworth-Heinemann, Stoneham, MA, USA (1994).
77. YEO SD, KIRAN E: Formation of polymer particles with supercritical fluids: a review. J. Supercrit. Fluids (2005) 34(3):287-308.
78. MOHAMED RS, HALVERSON DS, DEBENEDETTI PG, PRUD'HOMME RK: Solids formation after the expansion of supercritical mixtures. In: Supercritical Fluid Science and Technology. KP Johnston, JML Penninger (Eds), ACS symposium Series 406, Washington DC, USA (1989):355-378.
79. DOMINGO CE, BERENDS CE, VANROSMALEN GM: Precipitation of ultrafine organic crystals from the rapid expansion of supercritical solutions over a capillary and a frit nozzle. J. Supercrit. Fluids (1997) 10(1):39-55.
80. PETERSEN RC, MATSON DW, SMITH RD: The formation of polymer fibers from the rapid expansion of supercritical fluid solutions. Polym. Eng. Sci. (1987) 27(22):1693-1697.
81. PETERSEN RC, MATSON DW, SMITH RD: Rapid precipitation of low vapor-pressure solids from supercritical fluid solutions-the formation of thin films and fibers. J. Am. Chem. Soc. (1986) 108(8):2100-2102.
82. MAWSON S, JOHNSTON KP, COMBES JR, DESIMONE JM: Formation of poly(1,1,2,2-tetrahydroperfluorodecyl acrylate) submicron fibers and particles from supercritical carbon-dioxide solutions. Macromolecules (1995) 28(9):3182-3191.
83. WEBER M, THIES MC: Understanding the RESS process. In: Supercritical Fluid Technology in Materials Science and Engineering: Synthesis, Properties, and Applications. YP Sun (Ed.), Marcel Dekker, New York, NY, USA (2002):387-437.
84. GINOSAR DM, SWANK WD, MCMURTERY RD, CARMACK WJ: Flow-field studies of the RESS process. Proceedings of 5th International Symposium on Supercritical Fluids (2000).
85. SUN YP, ROLLINS HW: Preparation of polymer-protected semiconductor nanoparticles through the rapid expansion of supercritical fluid solution. Chem. Phys. Lett. (1998) 288(2-4):585-588.
86. SUN YP, RIGGS JE, ROLLINS HW, GUDURU R: Strong optical limiting of silver-containing nanocrystalline particles in stable suspensions. J. Phys. Chem. (1999) 103(1):77-82.
87. SUN YP, ROLLINS HW, GUDURU R: Preparation of nickel, cobalt, and iron nanoparticles through the rapid expansion of supercritical fluid solution (RESS) and chemical reduction. Chem. Mater. (1999) 11(1):7-9.
88. SUN YP, GUDURU R, LIN F, WHITESIDE T: Preparation of nanoscale semiconductors through the rapid expansion of supercritical solution (RESS) into liquid solution. Ind. Eng. Chem. Res. (2000) 39(12):4663-4669.
89. SUN YP, ATORNGITJAWAT P, MEZIANI MJ: Preparation of silver nanoparticles via rapid expansion of water in carbon dioxide microemulsion into reductant solution. Langmuir (2001) 17(19):5707-5710.
90. MEZIANI MJ, PATHAK P, ALLARD LF, SUN YP: Nanoparticle formation in rapid expansion of water-in-carbon dioxide microemulsion into liquid solvent. In: Supercritical Carbon Dioxide Separations and Processes. AS Gopalan, CM Wai, HK Jacobs (Eds), ACS Symposium Series 860, Washington DC, USA (2003):309-323.
91. MEZIANI MJ, ROLLINS HW, ALLARD LF, SUN YP: Protein-protected nanoparticles from rapid expansion of supercritical solution into aqueous solution. J. Phys. Chem. B (2002) 106(43):11178-11182.
92. MEZIANI MJ, SUN YP: Protein-conjugated nanoparticles from rapid expansion of supercritical fluid solution into aqueous solution. J. Am. Chem. Soc. (2003) 125(26):8015-8018.
93. MEZIANI MJ, PATHAK P, HARRUFF BA, HUREZEANU R, SUN YP: Direct conjugation of semiconductor nanoparticles with proteins. Langmuir (2005) 21(5):2008-2011.
94. ANIEDOBE NE, THIES MC: Formation of cellulose acetate fibers by the rapid expansion of supercritical methanol solutions. Macromolecules (1997) 30(9):2792-2794.
95. 2-soluble fluoropolymer. Ind. Eng. Chem. Res. (2002) 41(20):4976-4983.
96. DEBENEDETTI PG, TOM JW, YEO SD, LIM GB: Application of supercritical fluids for the production of sustained delivery devices. J. Control. Release (1993) 24(1-3):27-44.
97. MISHIMA K, MATSUYAMA K, TANABE D, YAMAUCHI S, YOUNG TJ, JOHNSTON KP: Microencapsulation of proteins by rapid expansion of supercritical solution with a nonsolvent. AIChE J. (2000) 46(4):857-865.
98. MATSUYAMA K, MISHIMA K, HAYASHI KI, ISHIKAWA H, MATSUYAMA H, HARADA T: Formation of microcapsules of medicines by the rapid expansion of a supercritical solution with a nonsolvent. J. Applied. Poly. Sci. (2003) 89(3):742-752.
99. LAVINE M: Capturing polymer nanoparticles. Science (2004) 303:927.
100. MARTIN AM: Drug product design. In: Physical Pharmacy. AM Martin (Ed.), Malvern, PA, USA (1993):512.
101. RASENACK N, MULLER, BW: Micron-size drug particles: Common and novel micronization techniques. Pharm. Dev. Design (2004) 9(1):1-13.
102. BITTNER B, MOUNTFIELD RJ: Intravenous administration of poorly soluble new drugs entities in early drug delivery: the potential impact of formulation on pharmacokinetic parameters. Curr. Opin. Drug Discov. Dev. (2002) 5(1):59-71.
103. GREF R, DOMB A, QUELLEC P, BLUNK T, MULLER RH, VERBAVATZ JM: The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Deliv. Rev. (1995) 16(2-3):215-233.
104. MERISKO-LIVERSIDGE E, SARPOTDAR P, BRUNO J et al.: Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer. Drugs. Pharm. Res. (1996) 13:272.
105. SONG CX, LABHASETWAR V, MURPHY H et al.: Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J. Control. Release (1997) 43(2-3):197-212.
106. ILLUM L, DAVIS SS, WILSON CG, THOMAS NW, FRIER M, HARDY JG: Blood clearance and organ deposition of intravenously administered colloidal particles. Effect of particle size, nature, and shape. Int. J. Pharm. (1982) 2:135.
107. HANS ML, LOWMAN AM: Boidegradable nanoparticles for drug delivery and targeting. Curr. Opi. Solid State Mater. Sci. (2002) 6(4):319-327.
108. BARRATT G: Colloidal drug carriers: Achievements and perspectives. Cell. Mol. Life Sci. (2003) 60(1):21-37.
109. YOUNG J, TIMOTHY J, MAWSON S et al.: Rapid expansion from supercritical to aqueous solution to produce submicron suspension of water-insoluble drugs. Biotechnol. Prog. (2000) 16(3):402-407.
110. TOM JW, LIM GW, DEBENEDETTI PG, PRUDHOMME RK: Applications of supercritical fluids in the controlled release of drugs. ACS Symposium Series (1993) 514:238-257.
111. MOGHIMI SM, HUNTER AC, MURRAY JC: Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. (2001) 53(2):283-318.
112. STOLNIK S, ILLUM L, DAVIS SS: Long circulating microparticulate drug carriers. Adv. Drug Deliv. Rev. (1995) 16(2-3):195-214.
113. WOODLE MC: Controlling liposome blood clearance by surface grafted polymers. Adv. Drug Deliv. Rev. (1998) 32(1-2):139-152.
114. GREF R, MINAMITAKE Y, PERACCHIA MT, TRUBETSKOY V, TORCHILIN V, LANGER R: Biodegradable long-circulating polymeric nanospheres. Science (1994) 263(5153):1600-1603.
115. LEE JW, PARK JH, ROBINSON JR: Bioadhesive-based dosage forms: the next generation. J. Pharm. Sci. (2000) 89(7):850-856.
116. LEUNER C, DRESSMAN J: Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. (2000) 50(1):47-60.
117. SOMA CE, DUBERNET C, BARRATT G, BENITA S, COUVREUR P: Investigation of the role of the macrophages on the cytoxicity of doxorubicin-loaded nanoparticles on M5076 cells in vitro. J. Control. Release (2000) 68(2):283-289.
118. DAEMAN T, VELNOVA MJ, REGTS J et al.: Different intrahepatic distribution of phosphatidylglycerol and phosphatidylserine liposomes in rat. Hepatology (1997) 26(2):416-423.
119. ROMERO EI, MORILLA MJ, REGTS J, KONING GA, SCHERPHOF GL: On the mechanism of hepatic transendothelial passage of large liposomes. FEBS Lett. (1999) 448(1):193-196.
120. CHAROENCHAITRAKOOL M, DEHGHANI F, FOSTER NR, CHAN HK: Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals. Ind. Eng. Chem. Res. (2000) 39(12):4794-4802.
121. SUN YP, ROLLINS HW, JAYASUNDRA B, MEZIANI MJ, BUNKER CE: Preparation and processing of nanoscale materials by supercritical fluid technology. In: Supercritical Fluid Technology in Materials Science and Engineering: Synthesis, Properties, and Applications. YP Sun (Ed.), Marcel Dekker, New York, NY, USA (2002):491-576.
122. MEDOFF G, BRAJTBURG J, KOBAYASHI GS, BOLARD J: Antifungal agents useful in therapy of systemic fungal infections. Ann. Rev. Pharmacol, Toxicol. (1983) 23:303-330.
123. GALLIS HA, DREW RH, PICKARD WW: Amphotericin-B- 30 years of clinical-experience. Rev. Infect. Dis. (1990) 12(2):308-329.
124. JULIANO RL, LOPEZ-BERESTEIN G, HOPFER R, MEHTA R, MEHTA K, MILLS K: Selective toxicity and enhanced therapeutic index of liposomal polyene antibiotics in systemic fungal-infections. Ann. NY Acad. Sci. (1985) 446:390-402.
125. MINONES J Jr, DYNAROWICZ-LATKA P, CONDE O, MINONES J, IRIBARNEGARAY E, CASAS M: Interactions of amphotericin B with saturated and unsaturated phosphatidylcholines at the air/water interface. Colloids Surf.B. Biointerfaces (2003) 29(2-3):205-215.
126. FUKUI H, KOIKE T, SAHEKI A, SONOKE S, SEKI J: A novel delivery system for amphotericin B with lipid nano-sphere (LNS). Int. J. Pharm. (2003) 265(1-2):37-45.
127. ATKINSON AJ, BENNETT JE: Amphotericin B pharmacokinetics in humans. Antimicrob. Agents Chemother. (1978) 13(2):271-276.
128. NAGAYASU A, UCHIYAMA K, KIWADA H: The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv. Drug Deliv. Rev. (1999) 40:75-87.
129. HANCOCK BC, ZOGRAFI G: Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. (1997) 86(1):1-12.
130. HORTER D, DRESSMAN JB: Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug. Deliv. Rev. (2001) 46(1-3):75-87.